IP Library Patent Application 10612358
Patent Application
App. No. 10/612,358

Methods for diagnosis of allergic bronchopulmonary aspergillosis

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
10/612,358
Abstract

A method for the diagnosis of ABPA in a human individual, comprising determining if the individual carries antibodies reactive with one or more ABPA-related recombinant allergens.

Claims (11)

1 - 13 . (canceled)

14 . A method for the diagnosis of ABPA in a human individual, comprising determining if the individual carries antibodies reactive with one or more ABPA-related recombinant allergens which discriminate with 100% specificity between ABPA and allergic sensitization to A. fumigatus.

15 . The method according to claim 14 , wherein the allergen is derived from A. fumigatus.

16 . The method according to claim 15 , wherein the allergen corresponds to a non-secreted protein from A. fumigatus.

17 . The method according to claim 14 , wherein an in vitro immunoassay is carried out on a fluid sample from the individual for the determination of the level of antibodies directed towards said recombinate allergens.

18 . The method according to claim 17 , wherein antibodies of the IgE class or IgE class, or subclasses thereof, are determined.

19 . The method according to claim 17 , wherein antibodies of the IgE class are determined.

20 . The method according to claim 14 , wherein an in vivo test is carried out in the individual.

21 . The method according to claim 20 , wherein the test is a skin test involving placing said one or more ABPA-related recombinant allergens in the skin of the patient.

22 . The method according to claim 20 , wherein antibodies of the IgE class or IgE class, or subclasses thereof, are determined.

23 . The method according to claim 20 , wherein antibodies of the IgE class are determined.

Assignments (3)
CHANGE OF NAME Recorded Oct 10, 2006
From: PHARMACIA DIAGNOSTICS AB
To: PHADIA AB
Reel/Frame 018375/0446 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 5, 2004
From: PHARMACIA & UPJOHN DIAGNOSTICS AB
To: PHARMACIA DIAGNOSTICS AB
Reel/Frame 015043/0694 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 18, 1999
From: CRAMERI, RETO; HEMMANN, STEFANIE; BLASER, KURT
To: PHARMACIA & UPJOHN DIAGNOSTICS AB
Reel/Frame 010174/0837 →